Form A botulinum toxin has widened its medical selection of apps, but the potential risk of building antibodies limitations the recurring usage of substantial-dose injection. Other serotypes of botulinum toxin are increasingly being investigated as practical options.Kara Rogers would be the senior editor of biomedical sciences at Encyclopædia Brit